Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NYGXM
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Palivizumab Conjugate 2
|
|||||
| Synonyms |
Palivizumab Conjugate 2
Click to Show/Hide
|
|||||
| Organization |
MERSANA THERAPEUTICS, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
6.8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Palivizumab
|
Antibody Info | ||||
| Antigen Name |
Respiratory syncytial virus fusion glycoprotein (RSV F protein)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||